Short Interest in Concord Medical Services Holdings Limited (NYSE:CCM) Grows By 134.9%

Concord Medical Services Holdings Limited (NYSE:CCM) saw a large growth in short interest during the month of May. As of May 15th, there was short interest totaling 7,483 shares, a growth of 134.9% from the April 30th total of 3,186 shares. Currently, 0.3% of the company’s stock are short sold. Based on an average daily trading volume, of 86,277 shares, the short-interest ratio is currently 0.1 days.

Concord Medical Services Stock Performance

Shares of CCM stock traded down $0.11 on Tuesday, reaching $4.82. 76,684 shares of the stock were exchanged, compared to its average volume of 62,888. The firm has a 50 day moving average of $4.29 and a two-hundred day moving average of $4.13. Concord Medical Services has a 1-year low of $3.18 and a 1-year high of $10.77. The company has a current ratio of 0.48, a quick ratio of 0.46 and a debt-to-equity ratio of 1.33.

Concord Medical Services (NYSE:CCM) last released its quarterly earnings data on Wednesday, April 29th. The company reported ($1.08) earnings per share (EPS) for the quarter.

Analysts Set New Price Targets

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Concord Medical Services in a research note on Tuesday, May 26th. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company presently has a consensus rating of “Sell”.

About Concord Medical Services

Concord Medical Services Holdings Limited is one of China’s leading providers of radiotherapy equipment and oncology services. The company specializes in supplying and operating advanced radiotherapy machines, including linear accelerators, computed tomography (CT) simulators and brachytherapy units, to public and private hospitals. Through its integrated service model, Concord Medical Services delivers treatment planning, machine maintenance and clinical support to enhance the precision and effectiveness of cancer therapies.

Founded in 1997 and headquartered in Beijing, Concord Medical Services has developed an extensive network of oncology centers across major cities and provinces in China.